Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GMED has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
GMED stock price ended at $72.8 on , after losing-0.37%
The Globus Medical Inc stock price decreased by -0.37% on the last trading day (), dropping from 72.84 to 72.8. Throughout the last trading session, the stock experienced a fluctuation of 1.32% , ranging from a day low of $72.18 to a day high of 73.13. The price has declined in 5 of the last 10 days, resulting in a total change of 2.56% during this period. On the last day, trading volume decrease by -69.78K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 629.03K shares were traded, amounting to approximately 45.79M.
GMED Technical Signals
GMED(Globus Medical Inc Corp) has buy signals and sell signals now. The average turnover of GMED over the last 5 trading days is NaN. Overall, the technical indicator signals lean more toward a outlook in the mid-term.
GMED Moving Average Analysis
Globus Medical Inc's overall moving average trend leans more bullish as of Sunday, April 27, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $, and $. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $, and $. A break-down below any of these levels will issue sell signals.
GMED Short Selling Analysis
The short sale ratio of Globus Medical Inc(GMED) as of is %, dropping from last trading day. With decreasing price from to .
Technical Signal
Technical Signals Summary
Sell
Buy
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
Bullish Signals
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No Data
Bearish Signals
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
No Data
GMED
Name
Similarity
Up/Down
No Data
GMED Seasonality Analysis
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Globus Medical Inc (GMED.N) stock in has the highest probability of a positive return (%), while has the lowest probability (%).
Performance Seasonality
The chart shows Globus Medical Inc. (GMED)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Globus Medical Inc (GMED.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GMED has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Globus Medical Inc (GMED.N) stock in a year?
The radar chart shows that buying Globus Medical Inc (GMED.N) stock in has the highest probability of a positive return (45.45%), while has the lowest probability (45.45%).
How has Globus Medical Inc. (GMED)'s stock price performed over the past three years?
GMED's stock price fell by in Invalid Date,in by
Which bull technical signals does GMED have?
Bullish technical signals of GMED include:
Which bearish technical signals does GMED have?
Bearish technical signals of GMED include:
Is GMED a buy based on overall technical signals summary?
GMED has 1 buy signals and 3 sell signals now. Overall the technical rating for GMED is . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of GMED.
What is the trend of Globus Medical Inc (GMED)'s moving average?
Globus Medical Inc's overall moving average trend leans more bullish as of April 27 2025, with 2 negative signals and 2 positive signal.
What is price prediction for GMED stock next month?
The price prediction chart for Globus Medical Inc (GMED.N) stock, as of Invalid Date, forecasts a % change over the next month, based on its high correlation with stock patterns. The similarity between their price movements over the analyzed periods is %. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for GMED Stock?
Globus Medical (GMED) is expected to reach a price of **$86** by the end of 2025. This prediction is based on strong Q4 2024 results, with revenue topping forecasts and solid product launches. Analysts have set a price target range of $80 to $103, with positive outlooks on the Nevro acquisition and integration. However, integration risks and insider selling activity warrant caution.
What is price prediction 2030 for GMED Stock?
### **Price Prediction for GMED Stock by 2030**
Based on current trends and analysis, GMED stock is predicted to reach **$150 by 2030**. This forecast is supported by the company's strong earnings growth, successful integration of acquisitions like NuVasive, and expansion into new markets such as neuromodulation through the Nevro acquisition.
The stock's current price of $70 reflects its solid fundamentals, with a 57% rating on Benjamin Graham's value investor model, indicating low P/B and P/E ratios. Analysts expect continued growth, with a consensus price target of $98.92, suggesting significant upside potential over the next few years.
By 2030, GMED's focus on innovation, strategic acquisitions, and market expansion is expected to drive further growth, making $150 a reasonable target.